Posters with odd numbers will be presented in this session.
Basic sciences and the many faces of CMT
- P2:
Nathan
Donies
(University of Antwerp
,
Belgium)
SCREEN4PN: Efficient evaluation of therapeutic compounds for Charcot-Marie-Tooth disease using patient-derived induced motor neurons and neuromuscular organoids (abstract in pdf, 193 kb) -
P4:
Francesco
Gentile
(San Raffaele Scientific Institute
,
Italy)
Genetic and pharmacologic modulation of the ATF6 UPR-related pathway affect disease pathogenesis in CMT1B (abstract in pdf, 235 kb) -
P6:
Nathalie
Dirkx
(Hasselt University
,
Belgium)
Phenotypic and functional impairments in human CMT1A Dental Pulp Stem Cell-derived Schwann cells (abstract in pdf, 223 kb) -
P8:
Hanne
Jeurissen
(Hasselt University
,
Belgium)
Cellular stress responses induced by PMP22 overexpression in Charcot-Marie-Tooth disease type 1A (abstract in pdf, 225 kb) -
P10:
Akram
Khanghahi
(UAntwerpen - VIB Center for Molecular Neurology,
Belgium)
Modelling YARS-Related Charcot-Marie-Tooth Disease: Establishing a Link Between YARS1-related Neurodegeneration and Mitochondrial Dysfunction (abstract in pdf, 216 kb) -
P12:
Yara
Lambrechts
(BIOMED-UHasselt + VIB-KU Leuven
,
Belgium)
The impact of Schwann cell differentiation on transgene expression in human stem cells (abstract in pdf, 216 kb)
Methods: diagnostics/genetics of CMT neuropathies
-
P14:
Katherine
Forsey
(Charcot-Marie-Tooth Association
,
USA / UK)
An In Vitro Model for Motor Neurons Displays Axonal and Mitochondrial Deficiencies Associated With Charcot-Marie-Tooth Disease Type 2A (abstract in pdf, 221 kb)
-
P16:
Edouard
Berling
(Paris-Saclay
,
France)
Whole-Body muscle MRI in Non‑5q Spinal Muscular Atrophy: Patterns, Genotype Prediction, and Diagnostic Implications (abstract in pdf, 259 kb) -
P18:
Christopher J
Record
(UCL Queen Square IoN
,
UK)
A neuropathy-mitochondrial multidisciplinary team meeting: enhancing diagnosis (abstract in pdf, 210 kb)
Therapeutic approaches on CMT neuropathies
-
P20:
Laurence
Lee
(University College London
,
United Kingdom)
“Getting the Balance Right”: Co-creating a Sensory-Integrated Balance Programme for People Living with Charcot-Marie-Tooth Disease (abstract in pdf, 210 kb) -
P22:
Barbara
Chaloupek
(CMT-Austria Patients Self-help Organisation
,
Austria)
Patient survey: The lived experience with Charcot-Marie-Tooth in Austria: therapies actually used and medical care (abstract in pdf, 213 kb) -
P24:
Eleonora
Cavalca
(Fondazione IRCCS Istituto Neurologico Carlo Besta,
Italy)
Physiotherapy in Charcot-Marie-Tooth Disease: insights from the Italian CMT Registry (abstract in pdf, 233 kb) -
P26:
Martina
D'Agostino
(IRCCS Ca’ Granda Ospedale Maggiore Policlinico
, Italy)
AAV9 MFN1 gene therapy as proof of principle for the treatment of CMT2A (abstract in pdf, 214 kb)
Clinical Outcome Measures / Clinical Trials of CMT neuropathies
-
P28:
Ana Claudia
Mattiello-Sverzut
(Ribeirão Preto Medical School, University of São Paulo
,
Brazil)
Responses to the cardiopulmonary exercice test for upper limbs in children and adolescents with Charcot-Marie-Tooth disease (abstract in pdf, 228 kb)
Project concepts
- P30: Filippo Genovese (European CMT Federation (ECMTF), Belgium)
The European CMT Federation (ECMTF): A Unified Voice to Accelerate Research and Raise Awareness for CMT (abstract in pdf, 209 kb)
Late-breaking
- P32: Lydia Jestice (University of Sheffield, UK)
Investigating Axonal Transport In Charcot-Marie-Tooth Disease Type 2A Using A Pluripotent Stem Cell-based Model (abstract in pdf, 197 kb)